Evaluación y manejo del riesgo cardiovascular residual en el paciente con diabetes

Gimeno Orna, José Antonio; Ortez Toro, José Jorge; Peteiro Miranda, Carlos Miguel.
Endocrinol. diabetes nutr. (Ed. impr.) ; 67(4): 279-288, abr. 2020. tab, ilus
Artículo en Español | IBECS (España) | ID: ibc-194796

Documentos relacionados

  1. The changing landscape of atherosclerosis.
  2. The effects of olive oil and cholesterol enriched diets on aortic fatty streak development and lipid peroxidation in rabbits.
  3. The dawn of a new era of targeted lipid-lowering therapies.
  4. Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a).
  5. Optimal Dietary Strategies for Prevention of Atherosclerotic Cardiovascular Disease in Diabetes: Evidence and Recommendations.
  6. [Evolocumab (Repatha®) : new therapy ofhypercholesterolaemia for secondary prevention of atherosclerotic disease].
  7. [Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention].
  8. Control of intestinal lipoprotein secretion by dietary carbohydrates.
  9. Utility of arterial stiffness assessment in children.
  10. Is There a Need to Revise Goals in the Management of Dyslipidemias?